Johnson & Johnson stock price edges higher after hours as Tecvayli data and earnings loom
New York, Jan 15, 2026, 19:27 EST — After-hours
- J&J shares nudged up in extended trading after a volatile session.
- The drugmaker flagged new late-stage data for Tecvayli in multiple myeloma.
- Investors are circling the Jan. 21 results and 2026 outlook.
Johnson & Johnson shares (JNJ.N) rose about 0.5% in after-hours trading on Thursday to $219.57, after swinging between $215.93 and $219.73 during the regular session.
The healthcare conglomerate is set to report fourth-quarter results on Jan. 21, with Chief Executive Joaquin Duato and Chief Financial Officer Joseph Wolk scheduled to lead an 8:30 a.m. ET conference call. Guidance for 2026 is likely to do most of the work on the day. (Jnj)
Late on Wednesday,…
